サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1556839

シラミ治療の世界市場

Lice Treatment

出版日
ページ情報
英文 277 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
シラミ治療の世界市場
出版日: 2024年09月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 277 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

シラミ治療の世界市場は2030年までに13億米ドルに達する見込み

2023年に10億米ドルと推定されるシラミ治療の世界市場は、分析期間2023-2030年にCAGR 4.2%で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるOTC医薬品は、CAGR 4.5%を記録し、分析期間終了時には8億7,750万米ドルに達すると予測されます。処方薬セグメントの成長率は、分析期間中CAGR 3.8%と推定されます。

米国市場は2億7,390万米ドルと推定、中国はCAGR 7.1％で成長予測

米国のシラミ治療市場は、2023年に2億7,390万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを7.1%として、2030年までに2億7,210万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と4.5%と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界のシラミ治療市場- 主要動向と促進要因のまとめ

シラミ治療は公衆衛生にどのように不可欠か？

シラミ治療は、公衆衛生を維持する上で重要な役割を担っています。特に、学校や保育所のような共同生活環境では、シラミの蔓延が急速に広がる可能性があります。効果的なシラミの管理は、かゆみや炎症などの感染による不快感を和らげるだけでなく、ひっかき傷から起こりうる二次感染を防ぐためにも不可欠です。さらに、積極的なシラミ治療と予防は、教育現場での混乱を最小限に抑え、シラミの蔓延に関連しうる社会的スティグマを軽減する上で極めて重要です。蔓延に迅速かつ効果的に対処することで、地域社会はより高い衛生・健康水準を維持し、シラミの蔓延を抑えることができます。

シラミ治療の機能性を高めるイノベーションとは？

シラミ治療の技術革新は、その有効性と安全性を高め、無害なソリューションに焦点を当て、ユーザーの利便性を向上させています。最近の動向としては、頭皮に刺激が強く、特にお子様には危険な可能性のある従来の殺虫剤を使用することなく、天然酵素や植物由来の成分を使用してシラミを駆除する治療法の開発が挙げられます。これらの新しい製剤は、シラミの成虫を標的にするだけでなく、シラミの卵のライフサイクルも効果的に破壊するため、蔓延をより包括的に管理することができます。さらに、マイクロチャージ技術でシラミを殺す電気クシや、毛髪からシラミやシラミを直接吸引するように設計されたバキュームシステムなど、物理的なシラミ駆除方法も改良され、化学薬品を使わない治療法も提供されています。

シラミ治療は家庭や教育機関にどのような影響を与えますか？

シラミ治療が家庭や教育機関に与える影響は大きく、子供たちの健康状態や学校の運営効率に影響を与えます。効果的なシラミ対策により、子どもたちはシラミによる不快感や気晴らしから解放され、より良い学習環境を促進し、高い出席率を維持することができます。家庭にとっても、信頼できる安全なシラミ駆除の選択肢があることは、蔓延したシラミを迅速に解決することを意味し、子どもたちの精神的・肉体的な不快感や保護者のストレスを軽減します。シラミを管理するための十分な情報に基づいた方針と実践を実施する学校は、蔓延を防ぎ、蔓延の管理よりも教育に重点を置き、より健康的で包括的な地域環境を育むことができます。

シラミ治療市場の成長を促進する動向とは？

シラミ治療市場の成長を牽引しているのは、より安全で効果的な治療法に関する意識の高まりや、世界のシラミの発生率の上昇など、いくつかの動向です。保護者や学校が従来の化学薬品による治療の潜在的な危険性について知識を深めるにつれ、効果的で皮膚や環境に優しい治療法に対する需要が高まっています。さらに、旧来の化学薬品ベースの治療法に対する抵抗性から、シラミの耐性株に対処できる新しい製剤や方法が必要とされています。また、シラミの予防と治療に関する公衆衛生上の取り組みや教育キャンペーンも、認識を高め、シラミ感染に汚名を着せず、人々がより迅速かつ効果的に治療を受けるよう促すことで、市場の成長に寄与しています。このような動向は、シラミ治療市場の革新と開拓を促進し、消費者ニーズと公衆衛生基準を満たすために進化し続けることを保証しています。

調査対象企業の例（全43件）

  • Alliance Pharma Plc
  • Apothecary Products, LLC.
  • FloSonix
  • G. Pohl-Boskamp GmbH & Co.KG
  • Leeford Healthcare Ltd.
  • Marico Ltd.
  • MooGoo Skin Care.
  • NitNOT Eco Head Lice Treatments
  • NitWits
  • Oystershell Consumer Health, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24239

Global Lice Treatment Market to Reach US$1.3 Billion by 2030

The global market for Lice Treatment estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. OTC Medication, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$877.5 Million by the end of the analysis period. Growth in the Prescription Medication segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$273.9 Million While China is Forecast to Grow at 7.1% CAGR

The Lice Treatment market in the U.S. is estimated at US$273.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$272.1 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Lice Treatment Market - Key Trends and Drivers Summarized

How Is Lice Treatment Essential for Public Health and Hygiene?

Lice treatment plays a crucial role in maintaining public health and hygiene, particularly in communal environments like schools and daycare centers where infestations can spread quickly. Effective lice management is vital not only to alleviate the discomfort of infestation, including itching and irritation but also to prevent the secondary infections that can occur from scratching. Furthermore, proactive lice treatment and prevention are critical in minimizing disruptions in educational settings and reducing the social stigma that can be associated with lice infestations. By ensuring that infestations are dealt with swiftly and effectively, communities can maintain higher standards of hygiene and health, and reduce the spread of lice.

What Innovations Are Enhancing the Functionality of Lice Treatment?

Innovations in lice treatment are enhancing its effectiveness and safety, focusing on non-toxic solutions and improving user convenience. Recent advancements include the development of treatments that use natural enzymes or plant-based ingredients to kill lice without the use of traditional insecticides, which can be harsh on the scalp and potentially hazardous, especially for children. These newer formulations not only target adult lice but also effectively disrupt the life cycle of nits (lice eggs), ensuring more comprehensive management of infestations. Additionally, there are improvements in the physical methods of lice removal, such as electric combs that use microcharge technology to kill lice and vacuum systems designed to suction out lice and nits directly from the hair, offering non-chemical treatment alternatives.

How Does Lice Treatment Impact Families and Educational Institutions?

The impact of lice treatment on families and educational institutions is significant, influencing both the physical health of children and the operational efficiency of schools. Effective lice management ensures that children are free from the discomfort and distraction caused by lice, promoting a better learning environment and keeping school attendance high. For families, having reliable and safe lice treatment options means quicker resolution of infestations, lessening the emotional and physical discomfort for children and the stress on parents. Schools that implement informed policies and practices for managing lice can prevent widespread outbreaks and maintain a focus on education rather than infestation management, fostering a healthier and more inclusive community environment.

What Trends Are Driving Growth in the Lice Treatment Market?

Several trends are driving growth in the lice treatment market, including increased awareness about safer and more effective treatment options and the global rise in the incidence of lice infestations. As parents and schools become more informed about the potential hazards of traditional chemical treatments, there is growing demand for treatments that are both effective and gentle on the skin and environment. Additionally, resistance to older, chemical-based treatments has led to the need for new formulations and methods that can address resistant strains of lice. Public health initiatives and educational campaigns about lice prevention and treatment are also contributing to market growth by raising awareness and destigmatizing infestations, encouraging people to seek treatment more promptly and effectively. These trends are fostering innovation and development within the lice treatment market, ensuring it continues to evolve to meet consumer needs and public health standards.

Select Competitors (Total 43 Featured) -

  • Alliance Pharma Plc
  • Apothecary Products, LLC.
  • FloSonix
  • G. Pohl-Boskamp GmbH & Co.KG
  • Leeford Healthcare Ltd.
  • Marico Ltd.
  • MooGoo Skin Care.
  • NitNOT Eco Head Lice Treatments
  • NitWits
  • Oystershell Consumer Health, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Lice Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Incidence of Head Lice Infestations Drives Demand for Effective Lice Treatment Solutions
    • Health and Safety Concerns Propel the Adoption of Natural and Non-Toxic Lice Treatments
    • Focus on Head Lice Management in Schools Influence Demand for Regular Lice Screening and Treatment Solutions
    • Enhancements in Application and Effectiveness of Lice Treatment Devices Boost Consumer Acceptance
    • Market Expansion Through Online Retail Channels Enhances Accessibility of Lice Treatments
    • Integration of Telemedicine in Dermatology Supports Growth in Lice Treatment Consultations
    • Increasing Consumer Preference for Home-Based Remedies Influences Product Innovations
    • Social Stigma and Hygiene Concerns Drive Innovations in Discreet Lice Treatment Products
    • Growing Number of Daycare and Child Care Centers Increases Demand for Lice Prevention Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Lice Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Lice Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for OTC Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for OTC Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for OTC Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Prescription Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Prescription Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Prescription Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • JAPAN
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • CHINA
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • EUROPE
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Lice Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • FRANCE
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • GERMANY
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Lice Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • INDIA
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Lice Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lice Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Lice Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Lice Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
  • AFRICA
    • Lice Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Lice Treatment by Medication Type - OTC Medication and Prescription Medication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Lice Treatment by Medication Type - OTC Medication and Prescription Medication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Lice Treatment by Medication Type - Percentage Breakdown of Value Sales for OTC Medication and Prescription Medication for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Lice Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Lice Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030

IV. COMPETITION